Issue of Equity

AI SummaryClose X

Coiled Therapeutics plc announced the issuance of 934,783 new ordinary shares, comprising 434,783 to a consultant and 500,000 to a vendor, to settle outstanding amounts. These new shares will rank pari passu with existing shares and are expected to be admitted to trading on AIM around June 3, 2026. Following admission, the company's total issued share capital will be 426,791,322 ordinary shares, each carrying one vote. This issuance will dilute existing shareholders' percentage ownership but is a non-cash transaction to settle liabilities.

Disclaimer*

UK 100

Latest directors dealings